Intra-tumoural microvessel density in human solid tumours

British Journal of Cancer

Volumn 86, Issue 10, 2002, Pages 1566-1577

  Hasan, J ^a   Byers, R ^b   Jayson, G C ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Angiogenesis; Microvessel density; Solid tumours

Indexed keywords

ANGIOGENESIS; ANTIBODY SPECIFICITY; ARTICLE; CANCER SURVIVAL; CORPUS LUTEUM FUNCTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOLID TUMOR; TISSUE SECTION; TUMOR VASCULARIZATION;

ANTIBODIES, MONOCLONAL; CLINICAL TRIALS; DRUG RESISTANCE, NEOPLASM; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; THYMIDINE PHOSPHORYLASE; URINARY PLASMINOGEN ACTIVATOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037141345     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600315     Document Type: Article

References (130)

1. Prognostic relevance of microvessel density in colorectal tumours
2. Intratumoral microvessel density predicts local treatment failure of radically irradiated squamous cell carcinoma of the oropharynx
3. Measuring changes in human tumour vasculature in response to therapy using functional imaging techniques
4. Angiogenesis in ductal breast carcinoma. Comparison of microvessel density between primary tumour and lymph node metastasis
5. Tumour angiogenesis as a prognostic assay for invasive ductal breast carcinoma
6. Prognostic significance of tumour angiogenesis in primary fallopian tube cancer
7. Microvessel density quantification in breast carcinomas. Assessment by light microscopy versus a computer aided image analysis system
8. Prognostic value of intratumoral microvessel density, a measure of tumour angiogenesis, in node-negative breast carcinoma. Results of a multiparametric study
9. Angiogenesis in bladder cancer: Relationship between microvessel density and tumour prognosis
10. Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting
11. In vivo monitoring of tumour angiogenesis with MR imaging
12. MRI characterization of tumours and grading angiogenesis using macromolecular contrast media: Status report
13. Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis
14. Angiogenic factors in laryngeal carcinomas: Do they have prognostic relevance?
15. Vascularity index as a novel parameter for the in vivo assessment of angiogenesis in patients with cervical carcinoma
16. High tumour angiogenesis is associated with poorer survival in carcinoma of the cervix treated with radiotherapy
17. Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: Independence from tumour radiosensitivity
18. Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix
19. Prognostic significance of microvessel density in lymph node negative breast cancer
20. Heterogeneity and reproducibility of microvessel counts in breast cancer
21. Non-invasive vascular imaging: Assessing tumour vascularity
22. Angiogenesis is an independent prognostic factor in malignant mesothelioma
23. Angiogenesis and metastasis
24. Is determination of angiogenic activity in human tumours clinically useful?
25. The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus
26. Assessment of tumour vascularisation: Immunohistochemical and non-invasive methods
27. Vasculogenic mimicry and tumour angiogenesis
28. Anti angiogenesis: New concept for therapy of solid tumours
29. What is the role of thymidine phosphorylase in tumour angiogenesis?
30. Microvessel count predicts metastatic disease and survival in non-small cell lung cancer
31. Angiogenesis as a prognostic indicator of survival in non-small cell lung carcinoma: A prospective study
32. Tumour angiogenesis in node-negative breast carcinomas-relationship with epidermal growth factor receptor, oestrogen receptor and survival
33. Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count and computer image analysis
34. The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is upregulated in breast cancer epithelium and endothelium
35. Relationship of elevated tumour thymidine phosphorylase in node-positive breast carcinomas to the effects of adjuvant CMF
36. Association of tumour angiogenesis with bone marrow micrometastases in breast cancer patients
37. Angiogenesis: Pathological, prognostic, and growth factor pathways and their link to trial design and anticancer drugs
38. Assessment of tumour angiogenesis in invasive breast carcinomas: Absence of correlation with prognosis and pathological factors
39. Angiogenesis in pancreatic carcinoma
40. Expression of vascular endothelial growth factor in patients with testicular germ cell tumours as an indicator of metastatic disease
41. P-glycoprotein expression predicts response to chemotherapy in previously untreated advanced breast cancer
42. Tumour microvessel density, p53 expression, tumour size and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma
43. Clinical importance of determination of tumour angiogenesis in breast carcinoma: Much more than a new prognostic tool
44. Tumour angiogenesis predicts clinical outcome of node-positive breast cancer patients treated either with adjuvant hormone therapy or chemotherapy
45. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy
46. Determination of angiogenesis adds information to oestrogen receptor status in predicting the efficacy of adjuvant tamoxifen in node-positive breast cancer patients
47. 3: A new prognostic indicator in breast cancer
48. Prognostic significance of tumour vascularity
49. Clinical significance of determination of surrogate markers of angiogenesis in breast carcinoma
50. The angiogenic 'vascular endothelial growth factor/flk-1/KDR receptor' pathway in patients with endometrial carcinoma: Prognostic and therapeutic implications
51. Assessment of angiogenesis in breast carcinomas: An important factor in prognosis?
52. Vascular permeability factor expression and angiogenesis in cervical neoplasia
53. Association of angiogenesis in lymph node metastases with outcome of breast cancer
54. Is the relationship between angiogenesis and metastasis in breast cancer real?
55. Independent prognostic importance of microvessel density in clinically localised prostate cancer
56. The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients
57. Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer
58. Urokinase and macrophages in tumour angiogenesis
59. Tumour angiogenesis in advanced stage ovarian carcinoma
60. Angiogenesis assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer
61. Ulex Eurpaeus I lectin as a marker for vascular endothelium in human tissues
62. Breast tumours: Computer-assisted quantitative assessment with colour Doppler US
63. Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy: A multiparametric and immunohistochemical analysis
64. Potential role of microvessel density in predicting radiosensitivity of T1 and T2 stage laryngeal squamous cell carcinoma treated with radiotherapy
65. The methodology of quantitation of microvessel density and prognostic value of neovascularisation associated with long term survival in Japanese patients with breast cancer
66. Inhibition of vascular endothelial growth factor induced angiogenesis suppresses tumour growth in vivo
67. Breast cancer: Vascular density determined using CD 105 antibody correlates with tumour prognosis
68. An evaluation of tumour vascularity as a prognostic indicator in uveal melanoma
69. Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy treated node-negative breast cancer?
70. Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours
71. Quantitative relationship of intravascular tumour cells, tumour vessels and pulmonary metastases following tumour implantation
72. Breast cancer angiogenesis and tamoxifen resistance
73. Relation of neovascularisation to metastasis of non-small cell lung cancer
74. Tumour angiogenesis as a predictor of recurrence in gastric carcinoma
75. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma
76. Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry
77. Examining the technique of angiogenesis assessment in invasive breast cancer
78. Thymidine phosphorylase expression is associated with both increase of intraturmoral microvessels and decrease of apoptosis in human colorectal carcinomas
79. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma
80. Association between tumour angiogenesis and tumour cell shedding into effluent venous blood during breast cancer surgery
81. Tumour microvessel density and prognosis in node-negative breast cancer
82. Endothelial cell markers CD31, CD34, and BNH 9 antibody to H- and Y-antigens-evaluation of their specificity and sensitivity in the diagnosis of vascular tumours and comparison with von Willebrand factor
83. Tumour angiogenesis as a prognostic marker in infiltrating lobular carcinoma of the breast
84. Prognostic significance of tumour angiogenesis in epithelial ovarian cancer
85. Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen
86. Angiogenesis at the site of deepest penetration predicts lymph node metastasis of submucosal colorectal cancer
87. Neovascularisation in clinical stage A testicular germ cell tumour: Prediction of metastatic disease
88. JC70: A new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections
89. Non-small cell lung carcinoma tumour growth without morphological evidence of neoangiogenesis
90. Coexpression of VEGF and bFGF is associated with increased vascular density in head and neck carcinomas
91. Microvessel density as compared to the Chalkley count in a prognostic study of angiogenesis in breast cancer patients
92. Tumour angiogenesis and rectal carcinoma
93. Inhibition of growth of C6 glioma cells in vivo by expression of anti-sense VEGF sequence
94. Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis
95. Assessment of vascularity in histological sections: Effects of methdology and value as an index of angiogenesis on breast tumours
96. Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma
97. Up regulation of basic fibroblast growth factor in breast carcinoma and its relationship to vascular density, oestrogen receptor, epidermal growth factor receptor and survival
98. Neovascularisation in human cutaneous melanoma: A quantitative morphologcal and Doppler ultrasound study
99. The prognostic significance of tumour vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma: A quantitative histologic study
100. Angiogenesis is prognostically important in vertical growth phase melanomas
101. The expression of basic fibroblast growth factor and vascular endothelial growth factor in prostatic adenocarcinoma: Correlation with neovascularisation
102. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer
103. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal type gastric cancer
104. Concentration of vascular endothelial growth factor in the serum and tumour tissue of brain tumour patients
105. Evaluation of angiogenesis in non-small cell lung cancer: Comparison between anti-CD34 antibody and anti-CD105 antibody
106. Association of tumour vasculature with tumour progression and overall survival of patients with non-early gastric carcinomas
107. Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularised human breast cancer
108. Tumour angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expression
109. Quantitative analysis of vascular endothelial growth factor in primary breast cancer
110. The human haematopoietic progenitor cell antigen (CD34) in vascular neoplasia
111. MRI enhancement and microvascular density in gliomas. Correlation with tumour cell proliferation
112. Correlation between tumour angiogenesis and expression of thymidine phosphorylase, and patient outcome in uterine cervical carcinoma
113. Bone marrow angiogenesis and progression in multiple myeloma
114. Mammary carcinoma model: Correlation of macromolecular contrast-enhanced MR imaging, characterisations of tumour microvasculature and histologic capillary density
115. Prognostic value of microvessel quantitation in cisplatin treated stage 3 and 4 ovarian cancer patients
116. Assessment of tumour vascularity as a prognostic factor in lymph node negative breast cancer
117. Microvessel quantification in primary colorectal carcinoma: An immunohistochemical study
118. Quantification of angiogenesis in solid human tumours: An international consensus on the methodology, and criteria of evaluation
119. Influence of investigator experience and microscopic field size on microvessel density in node-negative breast carcinoma
120. Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer
121. Association of angiogenesis and poor prognosis in node-positive patients receiving anthracycline-based adjuvant chemotherapy
122. Long term outcome of small size invasive breast carcinomas independent of angiogenesis in a series of 685 cases
123. Prognostic significance of image morphometric microvessel enumeration in breast carcinoma
124. Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastases: A morphometric study
125. Tumour angiogenesis and metastasis - Correlation in invasive breast carcinoma
126. Tumour angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma
127. Tumour angiogenesis correlates with metastasis in invasive prostate carcinoma
128. Determination of epidermal growth factor provides additional prognostic information to measuring tumour angiogenesis in breast carcinoma patients
129. Breast carcinoma: Comparative study of tumour vasculature using two endothelial cell markers
130. Angiogenesis as an unfavorable factor related to lymph node metastasis in early gastric cancer